Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Fusidic acid
Drug ID BADD_D00980
Description An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed) It acts by inhibiting translocation during protein synthesis. It is often used topically in creams and eyedrops but is available in systemic formulations including tablets and injections.
Indications and Usage For the treatment of bacterial infections.
Marketing Status approved; investigational
ATC Code D06AX01; D09AA02; J01XC01; S01AA13
DrugBank ID DB02703
KEGG ID D04281
MeSH ID D005672
PubChem ID 3000226
TTD Drug ID D0X7XG
NDC Product Code 12836-0315
UNII 59XE10C19C
Synonyms Fusidic Acid | Acid, Fusidic | Stanicide | Fusidin | Silver Fusidate | Fusidate, Silver | Fucithalmic | Fusidate Sodium | Sodium, Fusidate | Fusidic Acid, Sodium Salt | Sodium Fusidate | Fusidate, Sodium
Chemical Information
Molecular Formula C31H48O6
CAS Registry Number 6990-06-3
SMILES CC1C2CCC3(C(C2(CCC1O)C)C(CC4C3(CC(C4=C(CCC=C(C)C)C(=O)O)OC(=O)C)C)O)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abdominal pain upper07.01.05.003--
Administration site reaction12.07.04.011; 08.02.04.011--Not Available
Agranulocytosis01.02.03.001--Not Available
Anaemia01.03.02.001--
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.009--Not Available
Application site reaction12.07.01.006; 08.02.01.006--Not Available
Arrhythmia02.03.02.001--Not Available
Bone disorder15.02.04.004--Not Available
Burning sensation08.01.09.029; 17.02.06.001--Not Available
Cholestasis09.01.01.001--Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Dermatitis23.03.04.002--Not Available
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Drug interaction08.06.03.001--Not Available
Dyspepsia07.01.02.001--
Erythema23.03.06.001--Not Available
Eye disorder06.08.03.001--Not Available
Eye pain06.08.03.002--
Eye swelling06.08.03.003--Not Available
Flatulence07.01.04.002--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Immune system disorder10.02.01.001--Not Available
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.004--Not Available
The 1th Page    1 2 3    Next   Last    Total 3 Pages